Enovis to acquire eCential Robotics for €155 million

Enovis has made a binding offer to acquire eCential Robotics, a developer of surgical robotics and enabling technologies, for an upfront enterprise value of €155 million. The deal includes contingent consideration based on the achievement of specific milestones. The transaction is expected to close by the end of 2026, pending regulatory approvals.

Through this acquisition, Enovis intends to integrate robotics capabilities into its Astra enabling technology system, which currently utilizes augmented reality and procedure planning software. The company plans to launch a knee robot in late 2028, followed by a shoulder robot in 2029. Enovis CEO Damien McDonald stated that enabling technology is foundational to the company’s long-term growth strategy, aiming to differentiate its offerings from competitors through advanced features such as a robotic arm with seven degrees of freedom.